Medicare Enrolled

Dr. Mary Maier, MD

Allergy Physician · Silverdale, WA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
2011 NW MYHRE PL, Silverdale, WA 98383
3608301600
In practice since 2006 (20 years)
NPI: 1548234743 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Maier from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maier? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Maier

Dr. Mary Maier is an allergy physician in Silverdale, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Maier performed 1,972 Medicare services across 203 unique beneficiaries.

Between the years covered by Open Payments, Dr. Maier received a total of $1,399 from 18 pharmaceutical and/or device companies across 61 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Maier is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 50% volume in WA $1,399 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,972
Medicare services
Top 50% in WA for allergy physician
203
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~99 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Omalizumab injection (Xolair) for asthma/allergy 1,400 $30 $41
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
314 $3 $16
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
51 $11 $51
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
51 $62 $168
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
33 $79 $244
Health risk assessment administration and interpretation
This procedure involves administering a health risk assessment to a patient and interpreting the results.
27 $2 $30
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
26 $14 $46
Airflow rate measurement test
A test that measures the rate of airflow. This procedure assesses how quickly air moves.
24 $25 $86
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
20 $85 $230
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
13 $106 $353
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
13 $120 $319
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,399
Total received (2018-2024)
Avg $200/year across 7 years
Top 33% in WA for allergy physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
18
Companies
61
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,370 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$29 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$184
2023
$716
2022
$269
2021
$99
2020
$15
2019
$81
2018
$36

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$50
Takeda Pharmaceuticals U.S.A., Inc.
$34
CSL Behring
$29
AstraZeneca Pharmaceuticals LP
$28
Amgen Inc.
$24
Genentech USA, Inc.
$18
Top 3 companies account for 61.5% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$306
GENZYME CORPORATION
$258
ABBVIE INC.
$252
AstraZeneca Pharmaceuticals LP
$141
Genentech USA, Inc.
$70
Takeda Pharmaceuticals U.S.A., Inc.
$54
kaleo, Inc.
$54
Sunovion Pharmaceuticals Inc.
$43
PFIZER INC.
$33
CSL Behring
$29
Shire North American Group Inc
$26
Amgen Inc.
$24
Blueprint Medicines Corporation
$23
Pharming Healthcare, Inc.
$21
Grifols USA, LLC
$20
Merck Sharp & Dohme LLC
$18
BioCryst US Sales Co., LLC
$15
Genentech, Inc.
$12
Top 3 companies account for 58.3% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AUVI-Q · AYVAKIT · CIBINQO · CUVITRU · DERMATITIS - DISEASE · DUPIXENT · EUCRISA · FASENRA · Haegarda · LONHALA MAGNAIR · NUCALA · ORLADEYO · RINVOQ · RUCONEST · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · Utibron · Xembify · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an allergy physician in Silverdale?
Compare allergy physicians in the Silverdale area by procedure volume, costs, and industry payment transparency.
Browse allergy physicians nearby

Geographic Context

Allergy physicians within 10 mi
9
Per 100K population
3.3
County median income
$98,546
Nearest hospital
HARRISON MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Maier is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Maier experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Maier performed 1,400 omalizumab injection (xolair) for asthma/allergy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maier receive payments from pharmaceutical companies?
Yes. Dr. Maier received a total of $1,399 from 18 companies across 61 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maier's costs compare to other allergy physicians in Silverdale?
Dr. Maier's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maier) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →